Knowing nodal Rouviére:the power of human intelligence in toxicity reduction  

作　　者：Annie W.Chan 

机构地区：[1]Department of Radiation Oncology,Massachusetts General Hospital,Harvard Medical School,Boston,02114,MA,United States

出　　处：《Cancer Communications》2023年第5期613-614,共2页癌症通讯（英文）

摘　　要：Patients with nasopharyngeal carcinoma(NPC)represent a distinct group of head and neck cancer patients.They are often non-smokers,non-drinkers,and on average 10 to 20 years younger than those with cancers of other head and neck sites.Given good baseline health status and the effectiveness of contemporary treatment[1],patients with NPC typically have long projected life expectancies and commonly develop late treatment adverse effects,such as dysphagia and swallowing dysfunction.

关 键 词：NASOPHARYNGEAL YOUNGER SMOKE 

分 类 号：R739.63[医药卫生—肿瘤]